| نویسندگان | ستاره عیسائی,زهره زهرایی |
| همایش | یازدهمین کنگره بین المللی سرطان پستان |
| تاریخ برگزاری همایش | 2016-2-24 |
| محل برگزاری همایش | تهران |
| نوع ارائه | سخنرانی |
| سطح همایش | بین المللی |
چکیده مقاله
Breast cancer is the most common and the second leading cause of cancer
death in women. Researches show that mutation, gene amplification and
overexpression of growth factors especially fibroblast growth factors
(FGFs) are the main reasons in development of cancers which are
aggressive and almost resistant to treatments. 18 members of the FGF
family have been identified in mammalian that are grouped into 6
subfamilies based on sequence homology and phylogeny. FGF receptors are
the subfamily of tyrosine kinase receptors that are coding by 4 distinct
gene and they are specified for tissues by alternative splicing. FGFs are
involved in angiogenesis, embryonic development, wound healing, cell
proliferation, cell differentiation and different signaling pathways.
Methods:
In this study, related articles were studied to provide an overview of
changes in FGFs and their receptors in breast cancer.
Results:
The results showed that ectopic FGF signaling directly increases tumor
progression and angiogenesis. FGFs are activators of the
metalloproteinases secreted by cancer cells and are essential factors in
maintenance and enhancement of angiogenesis. FGF8b induces cell cycle
and is expressed in more than 50% of breast cancer tumors. INT2 gene
amplification has been observed in 22% of breast cancers that coded FGF3.
FGFR-1 genomic region (8P11-12), is one of the areas which has the most
amplification rate in breast cancer and its proliferation has been seen in
nearly 10% of breast cancer tumors.